DAINIPPON SUMITOMO PHARMA CO., LTD. : DSP and Takeda Announce

DAINIPPON SUMITOMO PHARMA CO., LTD. : DSP and Takeda Announce
Lurasidone, orally administrated once daily, is an atypical antipsychotic medication discovered and developed by DSP. In the U.S., it was approved for the and also for major depressive episodes associated with bipolar I … Read more on 4-traders (press release)


Tags: ,